ir.vivus.com
Investor Relations | VIVUS, Inc.The Investor Relations website contains information about VIVUS, Inc.'s business for stockholders, potential investors, and financial analysts.
http://ir.vivus.com/
The Investor Relations website contains information about VIVUS, Inc.'s business for stockholders, potential investors, and financial analysts.
http://ir.vivus.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
0.3 seconds
16x16
PAGES IN
THIS WEBSITE
13
SSL
EXTERNAL LINKS
109
SITE IP
23.213.123.49
LOAD TIME
0.263 sec
SCORE
6.2
Investor Relations | VIVUS, Inc. | ir.vivus.com Reviews
https://ir.vivus.com
The Investor Relations website contains information about VIVUS, Inc.'s business for stockholders, potential investors, and financial analysts.
ir.vivus.com
VIVUS, Inc. - VIVUS Reports Second Quarter 2015 Financial Results
http://ir.vivus.com/releasedetail.cfm?ReleaseID=924879
Laquo; Previous Release. Next Release ». VIVUS Reports Second Quarter 2015 Financial Results. MOUNTAIN VIEW, CA. The "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea and sexual health, today provided a business update, reported its financial results for the second quarter ended. June 30, 2015. And announced a restructuring plan. Seth H. Z. Fischer. In reviewing alternative proposals that will satisf...
VIVUS, Inc. - Download Library
http://ir.vivus.com/downloads.cfm
You are here: Home. 124; Download Library. Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files. Code of Business Conduct and Ethics. Cc ethics wb.pdf. Showing 1-10 of 16. Add file to Briefcase. Aug 26, 2016 - 4:00 PM ET.
VIVUS, Inc. - Shareholder Briefcase Registration
http://ir.vivus.com/briefcase.cfm
You are here: Home. 124; Shareholder Briefcase Registration. Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. Please fill in the form below to access this feature. Fixed Income Analyst (sell-side). Fixed Income Analyst (buy-side). Portfolio Manager (Fixed Income). Type in number *. This helps VIVUS, Inc. prevent automated submissions.
VIVUS, Inc. - Corporate Governance
http://ir.vivus.com/governance.cfm
You are here: Home. 2013 Declaration of Compliance to our California Comprehensive Compliance Program. Code of Business Conduct and Ethics. To request a copy of the 2010 Declaration of Compliance to our California Comprehensive Compliance Program, please phone toll-free: 1-888-345-6873. The Audit Committee is responsible for. Overseeing the accounting, financial reporting and audit processes;. Making recommendations to the Board of Directors regarding the selection of independent auditors;. Developing an...
VIVUS, Inc. - Press Releases
http://ir.vivus.com/releases.cfm
You are here: Home. 124; Press Releases. VIVUS Reports 2016 Second Quarter Financial Results. Aug 4, 2016. MOUNTAIN VIEW, CA - (Marketwired) - 08/04/16 - VIVUS, Inc. (NASDAQ: VVUS) (The "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today provided a business update and reported its financial results for the second quarter ended June 30, . Jul 27, 2016. Jul 26, 2016. Jul 21, 2016. MOUNTAIN VI...
TOTAL PAGES IN THIS WEBSITE
13
Risk Evaluation and Mitigations Strategy (REMS)
http://www.vivus.com/medical-affairs/rems-program
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. A Risk Evaluation and Mitigation Strategy (REMS) is a strategy to manage known or potential serious risks associate with a drug product and is required by the Food and Drug Administration (FDA) to ensure that the benefits of a drug outweigh its risks. The FDA has required a REMS for Qsymia. The purpose of the Qsymia. REMS is to inform prescribers and females of reproductive potential about the:. Need to discontinue Qsymia.
Clinical Trials
http://www.vivus.com/component/fpss/track/6/L2NsaW5pY2FsLXRyaWFscw,,
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. VIVUS is dedicated to bringing education and awareness of our clinical trials to patient and healthcare communities. If you are a patient looking for information about clinical trials, please begin by selecting a trial below. If you are a healthcare professional, we welcome you to join our clinical community. Please see the Contact Us. Page for more information. Contact Us/Info. Request.
Medical Affairs
http://www.vivus.com/component/fpss/track/7/L21lZGljYWwtYWZmYWlycw,,
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. VIVUS' Medical Affairs primary key responsibilities include:. Risk Evaluation and Mitigation Strategy (REMS) Program. Medical Information ( medical information and call center). Adverse Event (AE) Reporting. Product Complaint (PC) Reporting. For Adverse Event (AE) or Product Complaint (PC) Reporting. E-mail at vivus1@vivusmedinfo.com. To request Medical Information. Please complete and submit a Medical Request Information Form (MIRF):.
Products
http://www.vivus.com/products
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. For more information, click here. For more information, click here. Click below for full prescribing information:. For information about VIVUS' Products approved in the EU, click here.
Corporate Information
http://www.vivus.com/corporate-information
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets. VIVUS OAG Supply Chains Act Compliance Statement. Contact Us/Info. Request.
Medical Education (Grants)
http://www.vivus.com/medical-affairs/medical-education-grants
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. Vivus is also committed to supporting Continuing Medical Education (CME) and independent educational activities that will improve patient health through educating healthcare professionals. Vivus believes support should be aligned with the company’s areas of interest, be independent of Vivus, have scientific merit, and be conducted with the highest level of standards endorsed by the medical community. Medical education grant funding:.
VIVUS, Inc. - VIVUS Reports Second Quarter 2015 Financial Results
http://vvus.client.shareholder.com/releasedetail.cfm?ReleaseID=924879
Laquo; Previous Release. Next Release ». VIVUS Reports Second Quarter 2015 Financial Results. MOUNTAIN VIEW, CA. The "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea and sexual health, today provided a business update, reported its financial results for the second quarter ended. June 30, 2015. And announced a restructuring plan. Seth H. Z. Fischer. In reviewing alternative proposals that will satisf...
Management Team
http://www.vivus.com/corporate-information/management-team
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. Seth H.Z. Fischer. John L. Slebir, Esq. Senior Vice President Business Development and General Counsel. Mark K. Oki. Chief Financial Officer and Chief Accounting Officer. Santosh T. Varghese, MD. Vice President, Chemistry, Manufacturing and Control. Vice President, Marketing. Sandra E. Wells, Ph.D. Vice President, Patents and Assistant General Counsel. VIVUS OAG Supply Chains Act Compliance Statement. Seth H.Z. Fischer. Mark K. Oki.
Newsroom
http://www.vivus.com/newsroom
VIVUS OAG Supply Chains Act Compliance Statement. AE and PC Reporting. The Newsroom section provides easy access to VIVUS information for stories in development. It also houses our recent and archived press releases. Monday, August 29, 2016. VIVUS Extends Return Date of STENDRA Commercial Rights. Thursday, August 4, 2016. VIVUS Reports 2016 Second Quarter Financial Results. Wednesday, July 27, 2016. VIVUS Files Lawsuit Against Hetero for Infringement of Stendra Patents. Tuesday, July 26, 2016.
TOTAL LINKS TO THIS WEBSITE
109
Cimpress N.V. - Investor Relations - Investor Relations
Cimpress N.V. (Nasdaq: CMPR) is the world leader in mass customization. For 20 years, the company has focused on developing software and manufacturing capabilities that transform traditional markets in order to make customized products accessible and affordable to everyone. Financial Reports and Presentations. Cimpress NV Investor Day 2015. 160;at 8:30 am ET. Cimpress NV Fourth Quarter Fiscal Year 2015 Earnings Live Q&A session. 160;at 7:30 am ET. Cimpress Q4 Fiscal Year 2015 Earnings Press Release.
Vita34
Mo-Fr 8:00 – 19:00. Decl of Compliance and Report. Report of the Sup. Board. Annual financial report 2017 (PDF). DGAP-DD: Vita 34 AG english. Welcome to the Vita 34 AG Investor Relations website. We would be more than happy to answer your questions directed at ir@vita34group.de. Deutscher Platz 5 04103 Leipzig, Germany Phone: 49 (0)341 48792-40. Fax: 49 (0)341 48792-39 E-Mail: ir@vita34.com.
Vita34
Produkte von Vita 34. Mo-Fr 8:00 – 19:00. Erklärung zur Unternehmensführung und Bericht. Veröffentlichung gemäß 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung. Herzlich Willkommen auf der Internetseite Investor Relations der Vita 34 AG. Gerne beantworten wir Ihre Fragen unter ir@vita34group.de. Deutscher Platz 5 04103 Leipzig Tel: 49 341 487 9240. Fax: 49 341 487 9239 E-Mail: ir@vita34.de. Kostenfreie Beratung zur Einlagerung von Stammzellen. Unter 0800 034 0000 (Deutschland).
VIVER
History and Corporate Profile. Vision, Mission and Values. Board of Executive Officers. Presentations and Conference Calls. Announcements and Notices to Shareholders. Minutes and Documents for Meetings. History and Corporate Profile. Vision, Mission and Values. Board of Executive Officers. Presentations and Conference Calls. Announcements and Notices to Shareholders. Minutes and Documents for Meetings. Presentations and Conference Calls. Is a format of Internet news distribution, such as VIVER's.
Viveve Medical, Inc. (VIVMF)
Talk of the Town. Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women’s health company based in Sunnyvale, California. The company is focused on the commercialization of a revolutionary, non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. Viveve treats the condition of vaginal laxity, which is the result of the over stretching of the vaginal tissue during childbirth. Aug 11, 2015 8:28 AM EDT. Sign Up For Email Alerts. August 14, 2015.
Investor Relations | VIVUS, Inc.
Skip to main navigation. Stock Information Historical Lookup. Financial Information SEC Filings. With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We are a focused organization with the expertise and insights to advance innovative new therapies. Mar 13, 2018. VIVUS Reports Fourth Quarter 2017 Financial Results. Dec 26, 2017. View All Press Releases.
VMware, Inc. - Overview
Hybrid Cloud and Data Center Infrastructure. VMware Cloud on AWS*. Networking and Security Services. Located on our new VMware Cloud website. Digital Workspace and Desktop. Data Center and Cloud Infrastructure. VSphere with Operations Management. VRealize Business for Cloud. VMware Integrated OpenStack Carrier Edition. Internet of Things (IoT). Desktop and Application Virtualization. VSphere with Operations Management. Login to My VMware. File a Support Request. View Filed Support Requests. Technology Al...
Vanguard Natural Resources, LLC | Investor Center |Investor Center
Q2 2015 Vanguard Natural Resources LLC Earnings Conference Call. 160;at 11:00 am ET. Vanguard Natural Resources, LLC Reports Second Quarter 2015 Results. Vanguard Natural Resources, LLC Schedules Conference Call and Webcast to Discuss Second Quarter 2015 Earnings Results. Vanguard Natural Resources, LLC Announces Four Monthly Cash Distributions. Vanguard Natural Resources, LLC Announces Meeting Date and Record Date of 2015 Annual Meeting. Vanguard Natural Resources LLC 2015 Annual Meeting of Unitholders.
صدای آمریکا
جهش به محتوای اصلی. جهش به صفحه اصلی. ورود / ثبت نام. صفحه آخر - بازپخش. جمعه ۱۰ فروردین ۱۳۹۷ ایران ۰۹:۵۷. رهبران دو کره ۷ اردیبهشت دیدار میکنند مقدمهای برای دیدار پرزیدنت ترامپ و رهبر کره شمالی. سرکرده القاعده در لیبی در حمله پهپاد آمریکا کشته شد. روسیه در اقدامی تلافی جویانه دستور اخراج ۶۰ دیپلمات آمریکایی را صادر کرد. رویترز: ایتالیا مخالف اعمال تحریم های جدید علیه ایران است. نخستین بار پس از سوء قصد طالبان، ملاله یوسفزی به پاکستان باز گشت. 171;مطالعه شادی یک کلاس محبوب دانشگاهی در آمریکا. دونالد ترام...
第一視頻集團有限公司
艾瑞諮詢 第一視頻打造最有 度 新聞媒體. 海外監管公告 - 中國手遊娛樂集團有限公司 - 股東特別大會通告. 有關手機遊戲業務的 非常重大出售事項 特別現金股息 及 復牌. 張力軍獲 中國 行業 品牌十大創新人物 獎.
